Tim Bohen’s Top Trade Idea

A down market didn’t stop these Oracle winners… ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ [StocksToTrade Live]( Top Trade Ideas From The Trading Desk of Tim Bohen Today was a bad day for the market but a good day for some Oracle winners… Dermata Therapeutics (NASDAQ: DRMA) spiked premarket this morning, pulled back, and then spiked again after the open. Oracle gave us the entry signal of $3.01 per share on the second spike. After it hit that, DRMA quickly topped out at $5 for a return of 66.11%*. To learn more about Oracle, our proprietary algorithmic trading tool, register for my[free live webinar tonight at 9 pm Eastern](. I’ll tell you all about it and how I use it every single day. Another big return came from Bone Biologics Corp. (NASDAQ: BBLG). This one also popped just after the open and we got the Oracle entry price of $2.61 per share. BBLG quickly peaked at $4.24, for a gain of 62.45%*. Tomorrow could be a good day for Shimmick Corp. (NASDAQ: SHIM). It looks like it might want to revisit recent highs. Shimmick Corp. (NASDAQ: SHIM) This is a very choppy stock so I urge caution when trading this one… However, wait for a possible entry opportunity if it retests resistance and dips… Don’t forget to register for my [Free live training webinar tonight at 9 pm Eastern]( to learn all my tips and tricks, plus what else is on my watchlist. Tim Bohen Lead Trainer, StocksToTrade   [Click Here to Unsubscribe]( 13809 Research Boulevard, Suite 500, Austin, TX 78750 This is for informational purposes only as StocksToTrade is not registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. StocksToTrade cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. StocksToTrade in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, StocksToTrade accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns. Copyright © StocksToTrade.com